GEM-X Single Cell 5’ Gene Expression Kits and Companion Reagents.

The NIH is seeking a sole‑source, firm‑fixed‑price purchase order for 10x Genomics’ GEM‑X Single Cell 5’ Gene Expression kits and related reagents. The kits will support single‑cell/nucleus transcriptomic profiling of ~96 study participants, extending an existing 10x Genomics data set for cardiometabolic disease research. 10x Genomics is the only authorized source for these proprietary products, and the government will consider capability statements from any other interested parties before finalizing the procurement. • Items: 2×48‑sample GEM‑X v3 kits, 2×4‑sample GEM‑X v3 kits, 4×GEM‑X Single Cell 5’ Chip kits (4‑chip each), 4×Dual Index Kit TT Set A (96 reactions each). • Delivery: Single‑source purchase; award expected within five days after the September 21, 2026 submission deadline. • Submission: Capability statements electronically to [email protected] by 9:00 a.m. EDT, Sept 21, 2026, referencing Notice No. 75N98026Q01198. • Purpose: Enable consistent, high‑throughput single‑cell gene‑expression analysis for a large cohort, facilitating discovery of molecular risk factors and therapeutic targets for cardiometabolic disease.